Companies

Biocon Q4 profit falls 42% to ₹123 crore due to Covid-19 impact

PTI New Delhi | Updated on May 15, 2020 Published on May 15, 2020

Signage for Biocon Ltd,   -  Bloomberg

Biotechnology major Biocon has reported a 42 per cent decline in its consolidated net profit to ₹123 crore for the quarter ended March 2020, mainly on account of one-time coronavirus-related impact on its biologics business.

The company had posted a net profit of ₹214 crore for the corresponding period of the previous fiscal, Biocon said in a statement.

Consolidated total income of the company rose up by 6 per cent to ₹1,644 crore as against ₹1,557 crore for the same period year ago, it added.

“Q4FY20 witnessed a muted growth of 6 per cent with revenues at ₹1,644 crore due to operational challenges including one-time Covid-19 related impact on our biologics business,” Biocon Executive Chairperson Kiran Mazumdar-Shaw said.

Small molecules and research services businesses, however, delivered robust growth of 15 per cent and 14 per cent, respectively, she added.

Consolidated net profit for the fiscal year ended March this year stood at ₹748 crore. It was ₹905 crore for the same period year ago, Biocon said.

Total income of the company rose to ₹6,529 crore for the fiscal year ended March 2020 as against ₹5,659 crore for the same period year ago, it added.

“On a full-year basis, we reported a revenue growth of 15 per cent led by a strong performance by biologics, which grew by 29 per cent, small molecules by 18 per cent and research services by 10 per cent. We believe that the Biologics business will recover in Q1FY21 and fully normalise from Q2FY21,” Mazumdar-Shaw said.

Net profit, before the exceptional item, was at ₹760 crore, a growth of 4 per cent, she added.

“We are dealing with unprecedented challenges related to Covid-19 and as a science-led company we are engaged in several initiatives spanning diagnostic tests, vaccines and therapies towards combating Covid-19,” Mazumdar-Shaw said.

Shares of Biocon were trading at ₹323.50 per scrip on BSE, down 3.52 per cent from their previous close.

Published on May 15, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.